A tablet looks finished long before the quality team is finished with it. It may be compressed, coated and packed, but the batch still needs evidence before it can move on. The lab is looking for smaller things that a production line cannot settle by sight alone. Moisture picked up during handling. A result close to a limit. A record that leaves one question open.
Those details sound minor until the batch is large. One doubtful result can hold stock, delay supply plans and send people back to the sample, the method or the equipment.
Why a good-looking tablet is not enough
The simplest error is not always visible. A tablet can have the right colour, shape and weight, but still need testing before anyone trusts the batch. Ingredients may not be spread evenly after mixing. A coating step may run well, while the laboratory still needs to confirm what the sample shows.
Quality control catches the gap between appearance and evidence. Labs do not test every tablet, because that would destroy the batch and make production impossible. They test samples taken under a procedure, then compare the results with the specification for that product.
The batch moves forward only when the evidence is strong enough. If a result does not fit, the question is not whether the tablets look fine. The question is why the test gave that result.
Where titration fits into the checks
Some tablet checks need a chemical reaction that can be measured, repeated and reviewed. For labs checking tablet samples against an approved method, a titrator gives the quality team controlled reagent dosing, endpoint detection and a saved calculation that can be checked later in the run record.
That gives the quality team a method, an endpoint and a result that can be checked if the batch is questioned later.
Titration may support assay work, acid and base measurements, chloride checks, water determination or other methods where the chemistry fits. The instrument is not the whole quality system. It helps remove one place where manual judgement can slow down a decision.
Moisture is a small number with a large effect
Water can cause trouble in quiet ways. Some powders pick up moisture from the air while they are weighed or transferred. Some finished tablets are more sensitive because the active ingredient, coating or storage conditions leave less room for error.
Karl Fischer titration is commonly used when the lab needs to measure water rather than guess at dryness. The method may be familiar, but the handling still matters. A sample left exposed for too long, a poor transfer or a cell that is not ready can make the result harder to defend.
The chemistry is only one part. The sample has to arrive in the right state, be prepared in the right way and leave a record the reviewer can follow.
What happens when a result does not fit
An unexpected result does not automatically mean the tablets are wrong. The lab may repeat the test because the first run was unclear. The reagent may need checking. The electrode may need cleaning. The sample may not have dissolved properly.
That pause is not a delay for its own sake. A manufacturer working under GMP has to know whether the issue belongs to the test, the sample or the production process. Sending the batch forward without that answer would only move the problem to a later, harder stage.
If the same concern appears again, the investigation becomes wider. Teams may look at raw material records, mixing time, compression settings or earlier batches made under similar conditions. Sometimes the finding is contained. Sometimes it points to a process that needs correcting before more tablets are made.
Why records matter as much as results
A result that cannot be reviewed is not much help. In a pharmaceutical lab, data integrity means the record has to show who ran the method, which version was used, what changed, how the calculation was made and whether anything unusual happened during the run.
This is where a small paperwork problem can become a real release problem. A missing signature, unclear correction or copied value may send the result back for explanation even when the chemistry looks acceptable. The batch waits because the record is not clean enough to support the decision.
Electronic records can help when they make the route easier to follow. They are not a way around judgement. They reduce the time lost to finding worksheets, checking copied figures and rebuilding the story after the analyst has moved on to another task.
How faster labs avoid repeat delays
The better labs are not necessarily running every test at a dramatic speed. More often, they have removed the habits that create repeat work. The method is current. Reagents are checked before the rush. Analysts know when a result needs a second look and when it can move to review.
They also know where a batch usually gets stuck. If moisture testing keeps causing questions, they tighten sample handling. If review queues are the problem, they look at records. If one instrument is carrying too many methods, they change the schedule rather than blaming the analyst every time.
Speed comes from making the same small decisions easier to make. Nobody has to guess which method applies, where the sample is waiting or who can explain the run.
The checks patients never see
The person collecting a prescription should not have to think about endpoint detection, moisture results or batch records. The tablet should already have passed through the questions that matter.
For manufacturers, those checks keep uncertainty away from the pharmacy shelf. A batch is not released because it looks close enough or because the production plan needs it. It moves because the evidence supports the decision.
Good quality control is often quiet from the outside. It catches the small problem while it is still in the lab, gives the team a clear route for checking it and stops a doubtful result from travelling further than it should.
